Source link : https://www.newshealth.biz/health-news/fda-advisors-say-more-data-needed-for-rsv-vaccines-in-young-kids/

FDA advisors said that more data are needed to fully understand if there are broader safety concerns related to use of respiratory syncytial virus (RSV) vaccines in young children after an mRNA vaccine trial was halted earlier this year. Moderna, which had been developing an mRNA vaccine candidate for RSV in infants and toddlers, notified […]

Author : News Health

Publish date : 2024-12-13 17:31:53

Copyright for syndicated content belongs to the linked Source.

Exit mobile version